Originally developed for Type 2 diabetes, these medications have proven highly effective for treating obesitya chronic condition affecting more than 40% of U.S
Mounjaro (tirzepatide): Mounjaro is the newest anti-diabetic injectable drug approved for type 2 diabetes
These effects are influenced by factors such as dosage and background medications
Consuming foods with soluble fiber creates short chain fatty acids like butyrate , which directly increases GLP-1 production
To view a copy of this licence, visit About this article Cite this article Gautam, M., Gunay, A., Chandel, N.S
How GLP-1 Medications Like Ozempic and Mounjaro Work You may have heard of Ozempic, Mounjaro and Wegovy